Kniest dysplasia is a moderately severe type II collagenopathy, characteriz
ed by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myo
pia, and hearing loss. Mutations in the gene that encodes type II collagen
(COL2A1), the predominant protein of cartilage, have been identified in a n
umber of individuals with Kniest dysplasia, All but two of these previously
described mutations cause in-frame deletions in type II collagen, either b
y small deletions in the gene or splice site alterations, Furthermore, all
but one of these mutations is located between exons 12 and 24 in the COL2A1
gene, We used heteroduplex analysis to identify sequence anomalies in five
individuals with Kniest dysplasia, Sequencing of the index patients' genom
ic DNA identified four new dominant mutations in COL2A1 that result in Knie
st dysplasia: a 21-bp deletion in exon 16, an 18-bp deletion in exon 19, an
d 4-bp deletions in the splice donor sites of introns 14 and 20, A previous
ly described 28-bp deletion at the COL2A1 exon 12-intron 12 junction, delet
ing the splice donor site, was identified in the fifth case. The latter thr
ee mutations are predicted to result in exon skipping in the mRNA encoded f
rom the mutant allele, These data suggest that Kniest dysplasia results fro
m shorter type II collagen monomers, and support the hypothesis that altera
tion of a specific COL2A1 domain, which may span from exons 12 to 24, leads
to the Kniest dysplasia phenotype, Am. J Med, Genet, 85:105-112, 1999, Pub
lished 1999 Wiley-Liss, Inc.dagger